Allurion Technologies (ALURD) Amortization of Deferred Charges (2022 - 2024)

Allurion Technologies (ALURD) Amortization of Deferred Charges (2022 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn -
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 107,000.00
Sep 30, 2024 107,000.00
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 315,000.00
Mar 31, 2024 315,000.00
Dec 31, 2023 966,000.00
Dec 31, 2023 966,000.00
Sep 30, 2023 342,000.00
Sep 30, 2023 342,000.00
Jun 30, 2023 458,000.00
Jun 30, 2023 458,000.00
Mar 31, 2023 317,000.00
Mar 31, 2023 317,000.00
Dec 31, 2022 364,000.00
Dec 31, 2022 364,000.00
Sep 30, 2022 208,000.00
Sep 30, 2022 208,000.00